Dulaglutide
INTERCEPT
Company n/r · Phase n/r · Completed · Enrollment 60000
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Initiation of dulaglutide, semaglutide or tirzepatide | Obesity + T2D | n/r | n/r | n/r | n/r |
| Initiation of sitagliptin | Obesity + T2D | n/r | n/r | n/r | n/r |